Nov 15, 2022 7:30am EST Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales
Nov 08, 2022 4:30pm EST Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement
Nov 03, 2022 7:30am EDT Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit
Oct 26, 2022 7:30am EDT Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study
Sep 22, 2022 8:07am EDT Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.
Sep 12, 2022 7:00am EDT Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference
Sep 06, 2022 4:00pm EDT Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY
Aug 16, 2022 7:31am EDT Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering
